NEW YORK, NY / ACCESSWIRE / October 3, 2017 / U.S. markets kicked off the fourth quarter in the green Monday as investors appear optimistic that the markets record run will continue. The Dow Jones Industrial Average gained 0.68 percent to close at 22,557.60, while the S&P 500 Index gained 0.39 percent to close at 2,529.12. The NASDAQ Composite Index rose 0.32 percent to close at 6,516.72. On Monday, the Institute for Supply Management reported its manufacturing index rose to 58.8 percent in August from 56.3 percent in July, August's reading was the highest since April 2011.

"Today is a continuation of potential enthusiasm on the tax front and the data this morning. That was a good manufacturing number," said Scott Wren, senior global equity strategist at Wells Fargo Investment Institute in St. Louis, Missouri, according to Reuters.

RDI Initiates Coverage on:

Dynavax Technologies Corporation
https://rdinvesting.com/news/?ticker=DVAX

Valeant Pharmaceuticals Intl Inc.
https://rdinvesting.com/news/?ticker=VRX

Dynavax Technologies Corporation's stock jumped 8.14% Monday, to close the day at $23.25. The stock recorded a trading volume of 3,618,947 shares, which was above its three months average volume of 2,911,770 shares. In the last year, Dynavax Technologies Corporation's shares have traded in a range of 3.20 - 23.67. The share price has gained 626.56% from its 52-week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $17.84 is greater than its 200-day moving average of $9.78. Shares of Dynavax Technologies have gained approximately 488.61 percent year-to-date.

Access RDI's Dynavax Technologies Corporation Research Report at:
https://rdinvesting.com/news/?ticker=DVAX

On Monday, shares of Valeant Pharmaceuticals Intl Inc. recorded a trading volume of 11,014,374 shares, which was below the three months average volume of 16,585,000 shares. The stock ended the day 2.02% higher at 14.62. The share price has gained 75.93% from its 52-week low with a 52-week trading range of 8.31 - 25.54.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $14.22 is greater than its 200-day moving average of $13.18. Shares of Valeant Pharmaceuticals Intl Inc. have gained approximately 0.69 percent year-to-date.

Access RDI's Valeant Pharmaceuticals Intl Inc. Research Report at:
https://rdinvesting.com/news/?ticker=VRX

Our Actionable Research on Dynavax Technologies Corporation (NASDAQ: DVAX) and Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com